Viatris: Looks Cheap, But Faces Continued Contraction
Source: SeekingAlpha
2025-12-22 07:48:39 ET
It has been nearly three years since I last reviewed the prospects for shares of Viatris ( VTRS ) . At the start of 2023, I wondered where the cure was after a disappointing performance since the 2019 mega tie-up between the off-patented businesses of Mylan and Pfizer....
Read the full article on Seeking Alpha
For further details see:
Viatris: Looks Cheap, But Faces Continued Contraction
Viatris Inc.
NASDAQ: VTRS
VTRS Trading
-3.24% G/L:
$13.735 Last:
4,592,056 Volume:
$13.77 Open:
VTRS Latest News
February 27, 2026 03:57:23 pm
Bastion Bets on Government Spending with $8 Million New Stake in Parsons
February 26, 2026 06:55:00 am
Viatris Maintains Dividend Policy for 2026 and Announces Quarterly Dividend
VTRS Stock Data
$18,451,353,349
1,140,252,173
N/A
503
N/A
Pharmaceuticals
Healthcare
US
Canonsburg
